Search

everythinglearnresearchcommunity

for

Search:↓

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Inhibiting certain brain neurons may reduce pain and anxiety in trigeminal neuralgia.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

New devices may treat heart failure more effectively than drugs.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Parry–Romberg Syndrome can involve the brain even without obvious symptoms, and a new diagnostic framework is suggested for early detection.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Baricitinib is effective and safe for treating severe alopecia areata.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Abrocitinib may effectively treat Lichen Planopilaris.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Baricitinib may effectively treat lichen planopilaris.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

EGFR inhibitors can cause unusual localized hair growth.

Baricitinib may help people with long-term alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.